Friday, January 07, 2022

My pictorial home page

I have just put up the 2021 edition. See here (

There are also backups of all my annual picture pages here

Fauci’s strategy Causing ‘Thousands of People’ to Die Each Month

While promoting the use of masks and vaccines to fight the coronavirus, Dr. Anthony Fauci and many U.S. health officials have discouraged the use of therapeutics.

In a conversation with his father Ron Paul, Republican Sen. Rand Paul said Fauci’s strategy is causing thousands of needless deaths every month.

“I think Fauci is of the philosophy that vaccines are incredibly successful and are the way to go versus therapeutics, for example,” Paul said.

“As the AIDS epidemic came up, he wanted to develop a vaccine. There’s nothing wrong with that.” Of course, this turned out to be unsuccessful — a vaccine for AIDS has still not been created.

In Paul’s eyes, Fauci did not learn from his mistake as he led the response to the coronavirus pandemic.

“I would venture to say that thousands of people die in our country every month now from COVID because he’s de-emphasized the idea that there are therapeutics,” he said.

While Paul’s claim may be unverifiable, it is correct that the Biden administration has hindered the availability of therapeutics to treat COVID-19.

In August, CBS News reported that the CDC had issued an advisory warning against the use of ivermectin to treat COVID-19. It said there was “insufficient data” to show the anti-parasite drug could treat the virus.

Ivermectin had already been approved by the FDA to treat conditions like head lice and rosacea in humans. The CDC said the drug was “generally safe and well tolerated” as a prescription for those issues.

However, the CDC’s warning against ivermectin as a COVID-19 treatment led to widespread disparaging of the drug. Establishment media outlets spoke out against its use, and doctors refused to prescribe it even as a last resort.

The FDA has not approved the use of ivermectin as a treatment for COVID-19


Mum woke from 28-day Covid coma after being treated with Viagra

A nurse fighting for her life in a 28-day Covid coma was saved after colleagues used Viagra to treat her.

Monica Almeida, 37, was just 72 hours from her ventilator being turned off when medics had the idea to use the erectile dysfunction drug, reports The Sun.

The level of oxygen the mum-of-two needed dropped by half and her condition improved after a week - meaning she made it home for Christmas.

Monica has now praised the quick-thinking doctors for using the drug, which helped opened up her airways.

The specialist respiratory nurse, from the UK, said: “I had a little joke with the consultant after I came round because I knew him.

“He told me it was the Viagra, I laughed and thought he was joking, but he said ‘no, really, you’ve had a large dose of Viagra’. “It was my little Christmas miracle.”

Monica, who treated Covid patients while working for NHS Lincolnshire, tested positive for the disease in October.

The double-jabbed mum had lost her sense of taste and smell and was coughing up blood by day four of her diagnosis.

After her oxygen levels dropped the next day, she went to hospital but was discharged with a prescription and no treatment.

Within just two hours of being home, Monica woke up unable to breathe and was rushed to Lincoln County Hospital where she went straight to the resuscitation room.

Medics battled to restore her oxygen levels to normal but her condition deteriorated and she was taken to ICU.

She was placed in a coma on November 16 with her condition so severe, her parents were told to fly from Portugal to England to say their goodbyes.

Monica said: “I could have been gone at just 37 years old, but I suppose I was a bit of a monkey and kept on fighting.”

With the prognosis looking bleak, doctors decided to use the unusual treatment to help Monica.

The brave Covid victim emerged from her coma on December 14 and was allowed to return home on Christmas Eve.

Viagra has previously been banded around as a possible way to treat Covid patients as the little blue pill dilates blood vessels and opens the airways.

Scientists are carrying out tests to determine whether it can be used in the same way as inhaling nitric oxide, which can boost oxygen levels in the blood.

Viagra can be given to Brit coronavirus patients if they have agreed to be in a study to try experimental drugs.

Monica said: “It was definitely the Viagra that saved me. “Within 48 hours it opened up my airways and my lungs started to respond.

“If you think how the drug works, it expands your blood vessels.

“I have asthma and my air sacs needed a little help.”

The mum is now recovering at her home with her husband Artur and two sons aged nine and 14.

She is now urging people to get the vaccine after being told she would have died if she hadn’t been jabbed.

Covid booster jabs offer the best chance to get through the pandemic, health officials have repeatedly said.

Monica said: “There are people out there saying the vaccine has killed people. I’m not denying there are people who react and get poorly with the vaccine, but when we look at the amount of deaths we have in unvaccinated people there is a big message there to have your jab.

“It does worry me, especially in Lincolnshire, that people are against having the vaccine.

“I never expected at 37 years of age to get as ill as I did. I never thought this would happen to me and I want people to take it more seriously.”


Active ingredient in magic mushrooms could help treat mental health disorders including PTSD, research suggests

Scientists say that small doses of the psychedelic drug psilocybin, found in 'magic' mushrooms are not only good at easing disorders resistant to treatment but they also have no short or long-term side effects in healthy people.

Researchers in a study led by the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King's College London, found that the drug can be given safely in doses of either 10mg or 25mg to up to six patients.

The report, in partnership with COMPASS Pathways, is an essential first step for experts to prove the safety and feasibility of drug psilocybin as a treatment alongside talking therapies for a range of conditions including treatment-resistant depression (TRD) and PTSD.

It is the first drug to go head-to-head with the traditional and often ineffective treatments on the market.

Early research hailed the mushroom as a promising treatment but no human trials have been conducted until now.

It is the first trial of its kind to thoroughly investigate the magic of the mushroom.

A sample of 89 participants who had not used psilocybin within a year were recruited to take part in the trial. Then 60 people were picked at random to receive either 10mg or 25mg of the drug in a controlled lab environment. The patients received one-to-one support from trained psychotherapists after the doses were administered.

A placebo drug was given to the remaining 29 participants who acted as the control group and were also given psychological support.

The participants were closely monitored for six to eight hours and they were then followed up for 12 weeks.

During this time, they were assessed to track the number of possible changes, including sustained attention, memory, planning, as well as their ability to process emotions.

Dr James Rucker, a clinical scientist from the National Institute for Health Research, was the study's lead author. He said: 'This rigorous study is an important first demonstration that the simultaneous administration of psilocybin can be explored further.

'If we think about how psilocybin therapy (if approved) may be delivered in the future, it's important to demonstrate the feasibility and the safety of giving it to more than one person at the same time, so we can think about how we scale up the treatment.'

Dr Rucker, who is also an honorary consultant psychiatrist at South London and Maudsley NHS Foundation Trust added: 'This therapy has promise for people living with serious mental health problems, like treatment-resistant depression (TRD) and PTSD.

'They can be extremely disabling, distressing and disruptive, but current treatment options for these conditions are ineffective or partially effective for many people.'

There were no suggestions that either of the psilocybin doses had any short or long-term negative effects on the participant and no one withdrew from the study.

Professor Guy Goodwin the chief medical officer at COMPASS Pathways, said: 'This study was an early part of our clinical development programme for COMP360 psilocybin therapy.

'It explored the safety and feasibility of simultaneous psilocybin administration, with one to one support, in healthy participants, and provided a strong foundation to which we have now added positive results from our Phase IIb trial in 233 patients with TRD, and from our open-label study of patients taking SSRI antidepressants alongside psilocybin therapy.

'We are looking forward to finalising plans for our phase three programme, which we expect to begin in Q3 2022.'

Since this study was conducted, the researchers have completed phase two of the study, which has explored the efficacy and safety of psilocybin in people living with TRD and PTSD, and are now analysing their findings.

This study was published in The Journal of Psychopharmacology.




Thursday, January 06, 2022

A sign of what’s to come for others? South Africa’s Omicron wave has ‘subsided’ after striking up to HALF of nation as doctor says they’re now in a ‘good place’

South Africa's Omicron wave has completely collapsed and the country has reached the 'turning point in the pandemic', a doctor on the frontline in Johannesburg claimed today amid growing hopes that Britain's outbreak will also be short-lived.

Professor Shabir Madhi, a vaccine expert at the University of the Witwatersrand, said the variant was 'very much subsiding' and had already 'pretty much subsided' in Gauteng — the first province to fall victim to the extremely-infectious variant.

He estimated up to 50 per cent of the country's 58.8million people caught Omicron since it first emerged, despite just 500,000 infections being recorded since the strain was first spotted on November 23.

While Covid infections soared to an 'unprecedented' level, Professor Madhi said there was a 'complete uncoupling' of hospitalisation and deaths. Figures show hospitalisations barely reached a third of rates seen in previous peaks, while fatalities stayed 10 times lower.

Professor Madhi told BBC Radio 4's Today programme: 'I think we are in a good place in South Africa and I think we've reached the turning point in this pandemic.'

It comes after another 8,078 cases were recorded in South Africa yesterday, a rise of 12 per cent in a week, after tumbling for 17 days in a row. Officially, daily cases peaked at nearly 27,000 on December 15.

Hospital admissions also rose 8 per cent with 309 reported, however they have also been trending downwards for the past fortnight. Deaths — the biggest lagging indicator — rose to 139, the highest since the Omicron wave took off. But they are still a far cry from the 600 per day at the peak of the Delta wave.

The shrinking wave comes despite only a quarter of South Africans being double-jabbed. There is growing hope that Britain's variant-fuelled outbreak will follow a similar trajectory, where more than 70 per cent have had two jabs and half have had three.

In London — the UK's Omicron epicentre — infections and hospitalisations appear to be flatlining already. There were 347 admissions in the capital on New Year's Day, the latest day with data, down 7 per cent compared to the previous week. It is the second day in a row admissions have fallen week-on-week.

While daily infections nationally are running at record levels — 218,000 Britons tested positive yesterday — the number of Covid patients in hospital is still a fraction of previous peaks.

There are 15,000 Covid inpatients now compared to nearly 40,000 last January and about a third of current patients are not primarily sick with the virus. Fewer sufferers are also requiring ventilation.

Professor Madhi told BBC Radio 4's Today programme: 'Across the country the wave is very much subsiding.

'Certainly, what was initially the epicentre Gauteng, the wave has pretty much subsided and what we’ve experienced is an unprecedented number of cases compared to what was experienced in the past.

Professor Madhi said: 'This time around it‘s probably been a greater proportion of the population that has been infected.

'South Africa does about one fourteenth of UK testing. So when we report about 25,000 cases per day you could probably multiply that by about 14.

'My estimate is it is about 40 to 50 per cent of people in South Africa possibly have been infected during the course of this particular wave.'

High levels of immunity among the population from previous Covid infections prevented further cases and drove down transmission, he said.

But Professor Madhi warned South Africa's experience with Omicron may not be replicated in the UK and other countries that do not have high levels of natural immunity.

Around three-quarters of South Africans are thought to have been infected before Omicron emerged, but just 25 per cent have had a least one Covid jab.

Experts estimate less than half of people in the UK have had Covid, while 90 per cent of over-12s have had at least one jab.

He said: 'The big question is whether immunity primarily through vaccination plays the same role against protecting against severe disease as does natural infection-derived immunity. And I believe it does.'

Professor Madhi said it is 'certainly unpredictable as to what the next variant will look like' but T-cell protection from infection and vaccination protects against severe disease and is 'relatively well-preserved'.

'So I think we are in a good place in South Africa and I think we've reached the turning point in this pandemic,' he added.


CDC: Omicron Now 95 Percent of All New US COVID-19 Cases

The COVID-19 Omicron variant accounted for approximately 95.4 percent of U.S. COVID-19 cases diagnosed in the week ended Jan. 1, said the Centers for Disease Control and Prevention (CDC) in an update published Tuesday.

With the CDC’s finding, it suggests Omicron is highly contagious, as it was able to displace the previously dominant Delta strain in only a few weeks. The Delta variant now accounts for about 4.6 percent of all cases, the CDC figures show.

About two weeks ago, the CDC reported that Omicron only accounted for about 38 percent of all COVID-19 cases for the week ending on Dec. 18. The agency significantly revised its estimates for Omicron’s prevalence for the week ending on Dec. 25 from 73 percent to about 58 percent.

The United States, meanwhile, set a global record of almost 1 million new coronavirus infections reported on Monday, according to a tally, nearly double the country’s peak of 505,109 hit just a week ago.

About 978,856 new infections that were reported Monday include some cases from Saturday and Sunday, when many states do not report. The average number of U.S. deaths per day has remained fairly steady throughout December and into early January at about 1,300, according to a Reuters tally.

“We are seeing more and more studies pointing out that Omicron is infecting the upper part of the body. Unlike other ones, the lungs who would be causing severe pneumonia,” World Health Organization (WHO) Incident Manager Abdi Mahamud told Swiss-based journalists on Tuesday.

He said it is good news, “but we really require more studies to prove that.”

Since the heavily mutated variant was first detected in November, WHO data show it has spread quickly and emerged in at least 128 countries. However, while case numbers have surged to all-time records around the world, the hospitalization and death rates are often lower than at other phases in the pandemic.

“What we are seeing now is … the decoupling between the cases and the deaths,” Mahamud said.


Frontline Doctor Highlights His Preferred COVID-19 Treatments

While the Omicron variant of COVID seems to be causing less severe disease than the Delta variant, it’s still landing some people in hospitals, highlighting the need for effective treatment before cases progress to that stage, a frontline doctor says.

Dr. Syed Haider has treated more than 4,000 COVID-19-positive patients so far during the pandemic. Just five ended up going to a hospital, and none have died.

The doctor said his preferred treatments include many off-label medications along with vitamins and supplements.

“Vitamin D is really important, ivermectin is important, fluvoxamine, hydroxychloroquine also works, it’s just a lot of people have been convinced that it doesn’t at this point, and are scared off of trying it,” Haider told NTD’s “Capitol Report.” “But I prefer ivermectin, fluvoxamine, Vitamin D, Vitamin C, quercetin, zinc.”

Ivermectin is an anti-parasitic that has had mixed results against COVID-19 in clinical trials and isn’t advised by the Food and Drug Administration to treat the disease. Fluvoxamine is an antidepressant that’s gaining popularity for use against COVID-19. Hydroxychloroquine is an anti-malarial that has shown some success in treating the disease. Quercetin is a plant pigment that’s not widely known yet as a treatment for COVID-19.

Haider has also recommended flax seed oil.

“One really easy thing that anyone can do is just follow the directions on a bottle of hydrogen peroxide, you can get this at the store, can dilute it down to 1 percent swish swish it through your nose, or swish it through your mouth and drip it into your nose or use a neti pot to rinse out your nose. And it’s not uncomfortable, it shouldn’t be burning, if it’s burning, you would want to dilute it a little bit more, and that kills the virus on contact,” he said.

Haider’s list differs from the National Institutes of Health’s recently updated treatment recommendations for non hospitalized COVID-19 patients.

The agency recommends using Pfizer’s COVID-19 pill, known as paxlovid; Merck’s pill, called molnupiravir; GlaxoSmithKline’s monoclonal antibody treatment, sotrovimab; or Gilead Sciences’s remdesivir, administered through IV over multiple days.

The recommendations stem from studies that demonstrate the therapeutics’ effectiveness, the agency said.

Haider, however, doesn’t agree with the remdesivir recommendation, noting it’s never received an endorsement from the World Health Organization and that it has the side effect of causing kidney failure.

The virus that causes COVID-19, he said, is “very, very easily treatable” if early treatment is done with off-label drugs, Haider stressed.

He advises people get prepared ahead of time.

“I think people need to take this seriously and get medications on hand before they get sick,” Dr. Syed Haider told “Capitol Report.”

While Omicron often manifests as a bad cold, even some people who are considered at low-risk of developing severe disease will end up with severe cases, the doctor said. Additionally, emerging data indicate that the protection provided by both vaccination and natural immunity isn’t as good against Omicron, emphasizing the need to be ready.




Wednesday, January 05, 2022

Why we shouldn’t yet be worried about the latest new Covid variant

Another day, another variant. While the reaction to Omicron was immediate and one laced with genuine fear and concern, the emergence of a new strain in southeastern France has been met with a shrug of the shoulders by many scientists.

On paper, B.1.640.2 looks problematic. Like Omicron, it has multiple mutations, 46 in total, many of which are located in its spike protein - the part of the virus responsible for gaining entry to human cells.

In reality, this is a variant that predates Omicron yet has failed to take off globally in the same way.

It appears to have first popped up on scientists’ radars in early November, when the first sequenced case of B.1.640.2 was uploaded from Paris to a global variant database called Gisaid.

The first sequence of Omicron was uploaded three weeks later, on 22 November, and in the time that followed has spread rapidly across the world, reaching all six continents by the turn of the new year.

In contrast, B.1.640.2 appears to have been limited to minor clusters here and there, as seen in southeastern France where 12 people were infected with the variant, according to a non peer-reviewed study released before Christmas.

The ‘index case’ - the first individual identified at the heart of a cluster - was vaccinated against Covid and had returned from Cameroon three days before his positive result. The study claims he developed “mild” respiratory symptoms the day before his diagnosis.

However, when the scientists took a dive into Cameroon’s own genomic data, they were unable to find any sequences of B.1.640.2, suggesting the variant either hasn’t been detected in the country yet, or originated from elsewhere.

Perhaps it could be the case that the French traveller had a fleeting encounter with someone in an airport who was infected with B.1.640.2. At this stage, we simply don’t know.

Regardless, the alarm bells have yet to be rung when it comes to this particular variant.

Tom Peacock, a virologist at imperial College, said B.1.640.2 was “not one worth worrying about too much” at the moment. “This virus has had a decent chance to cause trouble but never really materialised,” he said on Twitter.

Other close viral cousins of B.1.640.2 have similarly been in circulation for weeks, but have also struggled to make an impact.

As to why it has this variant hasn’t been as successful in spreading as Omicron - despite its high mutation count - we can only speculate.

Although B.1.640.2 carries many of the same mutations seen in previous variants of concern, much depends on how they combine with one another to shape the characteristics of the virus.

It could be the case that some of the mutations are actually detrimental to the virus’ ability to enter our cells or replicate, thus hindering its ability to rapidly spread.

Data on B.1.640.2 is light, and until scientists have more of it, it’s unlikely they’ll be able to provide a clear answer as to why this particular variant hasn’t come to dominate.

Should that remain the case, it will ultimately be a good thing. For now, Omicron is the main variant of concern. Unless the picture changes considerably for whatever reason, that should be the predominant focus of our attention and scientific endeavours in the weeks to come.


Puerto Rico Faces Staggering Covid Case Explosion

More evidence that vaccination is only weakly protective against Omicron

The island had a 4,600 percent increase in cases in recent weeks after mounting one of the nation’s most successful vaccination campaigns.

At one point this week, the daily case count had surpassed 11,000, a very high figure for an island with just 3.2 million inhabitants.

Armed with her vaccine passport and a giddy urge to celebrate the holiday season, Laura Delgado — and 60,000 other people in Puerto Rico — attended a Bad Bunny concert three weeks ago.

Three days later, she was sick with Covid-19, one of about 2,000 people who fell ill as a result of the two-day event.

“We did so well; we followed the rules,” said Ms. Delgado, a 53-year-old interior designer. “We followed the mask mandate. Our vaccination rate was so high that we let our guard down. The second Christmas came, we were like, ‘We’re going to party!’”

The superspreader concert helped usher in an explosion of Covid-19 cases in Puerto Rico, which until then had been celebrating one of the most successful vaccination campaigns in the United States.

The concert was one of a series of business events, company holiday parties and family gatherings that fueled a 4,600 percent increase in cases on the island, a surge that public health officials worry could linger into the New Year; the Puerto Rican holiday season stretches to Three Kings Day on Jan. 6.

While the Omicron variant has besieged the entire country, it is especially worrisome in Puerto Rico, a U.S. territory already overwhelmed by government bankruptcy, an exodus of health professionals and a fragile health care system. Officials imposed a new wave of tough restrictions on travelers and diners in hopes of staving off the new wave of cases.

Rafael Irizarry, a Harvard University statistician who keeps a dashboard of Puerto Rico Covid-19 data, tweeted the daunting facts: A third of all coronavirus cases the island has recorded since the start of the pandemic occurred in the past month. The number of cases per 100,000 residents jumped to 225, from three, in three weeks.

In December, the number of hospitalizations doubled — twice.

Without the polarizing politics that have plagued the debate over vaccines in other parts of the country, nearly 85 percent of those in Puerto Rico have received at least one vaccine dose, and about 75 percent have gotten both shots.

But in the face of a highly contagious new variant, a high vaccination rate is not that meaningful anymore, Mr. Irizarry said.


Governor Demands Biden Allow Florida to Purchase Blocked COVID Treatments

Florida Governor Ron DeSantis has long been a bit of an outlier on the national scene when it comes to COVID-19, erring proudly and loudly on the side of liberty in terms of vaccine and mask mandates. This has, unsurprisingly, put him in the crosshairs of the Biden administration on several different occasions, as the two spar over an issue of states’ rights.

The latest battlefield that these two governmental entities are meeting upon is that of monoclonal antibodies – some of the leading treatments of COVID-19 currently available.

Gov. Ron DeSantis, R-Fla., called for the Biden administration to allow his state to obtain more monoclonal antibody treatments as it encounters the omicron variant of COVID-19.

“We’re past the point now where we’re able to get it directly from any of these companies,” DeSantis said during a press conference on Monday. “The federal government has cornered the entire market. They basically took control of the supply in September.”

This is the latest in a disturbing trend that seems to have pit the federal government against the Sunshine State.

The governor’s press conference came nearly a week after his surgeon general, Dr. Joseph Ladapo, sent U.S. Health and Human Services Secretary Xavier Becerra a letter requesting the federal government restore distribution of monoclonal antibodies treatments to the state.

“The federal government is actively preventing the effective distribution of monoclonal antibody treatments in the U.S.,” Ladapo wrote. “The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state.”

As Ladapo’s letter noted, HHS said in September that it would determine state-by-state distribution of certain drugs. An official reportedly said the move would “help maintain equitable distribution, both geographically and temporally, across the country.”

As of this writing, the Biden administration has not responded to Florida’s request or accusations.




Tuesday, January 04, 2022

'We'll be in the throes of Omicron for a month': Ex-FDA commissioner says COVID will peak in two weeks

The Omicron variant is continuing to create a surge in new COVID-19 cases through the United States in the new year, with former FDA Commissioner Scott Gottlieb warning that we will be in the throes of the new wave in infections for the next month before cases drop off - even as the death rate remains relatively low.

The country recorded its highest seven-day average number of cases on January 2, with 413,304 people testing positive for the virus over the past week, according to data from Johns Hopkins University. At the same time, on a seven-day average, there were 1,350 new deaths. That number is far lower than the seven-day average recorded at the peak of winter in January 2021, where the US averaged around 3,300 deaths.

Cases may continue to rise over the next few days due to a lag in reporting over the weekend, and on Monday, Dr. Anthony Fauci told PIX 11 News: 'It is going to go higher.

'What we hope will happen is what we've seen in South Africa, you see a spike and then it turns around,' he said.

The country, which was one of the first in the world to fall victim to Omicron, hit its peak in the seven days leading up to December 17, when an average of 23,437 cases were recorded.

But by December 28, the number had plummeted by 38 percent to 14,390 cases.

Dr. Scott Gottlieb, the former FDA commissioner, also said on Monday that he believes 'this is not going to last very long,' estimating 'we'll be in the throes of this for maybe a month.'

'Here in the northeast, I think you're going to see infections peak out within the next two weeks,' he claimed in an interview on CNBC's Squawk Box. 'So hopefully, here in New York City does find a peak within the next two weeks.'

He said that London, which was struck by the Omicron wave several weeks before it came to New York City, 'has already peaked and is probably on the way down.' New York City saw 85,476 new cases reported in the state over the weekend, whereas London saw 19,951 on January 2.

Both Fauci and Gottlieb, as well as a number of other experts now say catching the highly-contagious Omicron variant could actually be beneficial to society, as it has been proven to be less virulent than other strains but could create herd immunity.

This comes after a study by Columbia University revealed that Omicron-fueled cases could peak to around 2.5 million by January 9 with others estimating the surge to go to 5.4 million.

Meanwhile, another covid variant has been found in France, according to scientists. The mutant strain has 46 mutations that are thought to make it both more vaccine-resistant and infectious than the original virus.

About 12 cases have been recorded so far near Marseille, with the first linked to travel to the African country Cameroon. But there is little sign that it is outcompeting the dominant Omicron variant, which now makes up more than 60 per cent of cases in France. It is yet to be spotted in other countries or labelled a variant under investigation by the World Health Organization.

In another interview with the Today Show's Hoda Kotb on Monday, former acting director of the Centers for Disease Control Richard Besser said he expects 'these next few weeks are going to be really rough in terms of numbers of new cases.'

Speaking to Danish TV 2, Tyra Grove Krause - the chief epidemiologist at Denmark's State Serum Institute - said a new study from the organisation found that the risk of hospitalisation from Omicron is half that seen with the Delta variant.

This, she said, has given Danish authorities hope that the Covid-19 pandemic in Denmark could be over in two months.

'I think we will have that in the next two months, and then I hope the infection will start to subside and we get our normal lives back,' she said on Monday.

Despite early fears that Omicron could prolong the pandemic due to its increased level of infection, Ms Krause said it actually could spell the end of the pandemic.

According to the study: 'Omicron is here to stay, and it will provide some massive spread of infection in the coming month. When it's over, we're in a better place than we were before.'

But while infection numbers in countries with the variant are soaring, the expert said that the highly infectious Omicron appears milder than the Delta variant, and therefore more people will be infected without having serious symptoms.

As a result, she said, this will provide a good level of immunity in the population.

Denmark has seen a spike in new cases in recent weeks, and on Sunday recorded its highest ever seven-day average infections, recording an average of 20,886 across the previous week, or 3,592.74 per million people - one of Europe's highest rates.

It reported its highest ever new infections on December 27 (41,035).

By comparison, the UK's seven-day average daily new confirmed Covid-19 cases per million people sits at 2,823.31 as on Monday, while in the United States, that number is 1,215.76 - lower than many countries in Europe.

Ms Krause stressed that there was still work to be done to beat the pandemic in the coming months, however.

'Omicron will peak at the end of January, and in February we will see declining infection pressure and a decreasing pressure on the health care system,' she said.

'But we have to make an effort in January, because it will be hard to get through.'

The epidemiologist said Danes should continue to follow the now well-known measures to help slow the spread, such as good hygiene, social distancing where possible, and staying at home when symptoms present themselves.

Omicron's increasing spread will continue to put pressure on Denmark's healthcare system, she said. 'This is definitely what will be the challenge in the future.'

Professor Lars Ƙstergaard, chief physician at the Department of Infectious Diseases at Aarhus University Hospital, also looked towards the end of the pandemic in comments made on January 1.

He said that while the coronavirus will not be characterised as a pandemic forever, it will likely never fully disappear.

I never think we'll ever wave goodbye to the corona,' he said.

'But we want such a good immunity in the population - partly because of new vaccines, partly because people have been infected - that we can handle it as another of the infections we know that come especially in the winter month.'

Ms Krause agreed, saying: 'In the long run, we are in a place where coronavirus is here, but where we have restrained it, and only the particularly vulnerable need to be vaccinated up to the next winter season.'

But, he said, 'this could be the path out of this pandemic - as this variant spreads around and infects more and more people.

'Hopefully, the protection you get from having had an Omicron variant will provide some protection from other variants,' he continued, noting: 'The key, I think, is focusing on global protection. We have done a terrible job at providing vaccines around the globe and as we've seen with Omicron, new variants can arise anywhere.

'So from an equity and justice standpoint, we need to do more - but in terms of our self interest and being protected against future variants we need to do a lot more to make vaccines available.'

As of Monday, 9.2 billion people worldwide have received at least one dose of a COVID vaccine, and as of Thursday, 73.3 percent of all Americans have received at least on dose and 62 percent are fully vaccinated.

But just 33.4 percent of all fully-vaccinated Americans have received a booster dose, according to data from the Centers for Disease Control, as federal health officials consider changing the definition of 'fully vaccinated' to include booster doses amid a surge in children being hospitalized with the virus.

A Danish health official has also said that the Omicron variant is bringing about the end of the pandemic, saying 'we will have our normal lives back in two months'.

Speaking to Danish TV 2, Tyra Grove Krause - the chief epidemiologist at Denmark's State Serum Institute - said a new study from the organization found that the risk of hospitalization from Omicron is half that seen with the Delta variant.

This, she said, has given Danish authorities hope that the Covid-19 pandemic in Denmark could be over in two months.

'I think we will have that in the next two months, and then I hope the infection will start to subside and we get our normal lives back,' she said on Monday.

Despite early fears that Omicron could prolong the pandemic due to its increased level of infection, Ms Krause said it actually could spell the end of the pandemic.

According to the study: 'Omicron is here to stay, and it will provide some massive spread of infection in the coming month. When it's over, we're in a better place than we were before.'

But while infection numbers in countries with the variant are soaring, the expert said that the highly infectious Omicron appears milder than the Delta variant, and therefore more people will be infected without having serious symptoms.

As a result, she said, this will provide a good level of immunity in the population.

Denmark has seen a spike in new cases in recent weeks, and on Sunday recorded its highest ever seven-day average infections, recording an average of 20,886 across the previous week, or 3,592.74 per one million people - one of Europe's highest rates.

It reported its highest ever new infections on December 27, with 41,035 new cases.

As of Monday, the United States saw 254,091 new cases with just 244 new deaths. That number is likely to be higher due to a lag in reporting over the weekend.

But other experts have said that society is going to have to live with COVID, with Dr. Albert Ko, an infectious disease specialist at the Yale School of Public Health saying: 'Certainly COVID will be with us forever.

'We´re never going to be able to eradicate or eliminate COVID, so we have to identify our goals.'

At some point, the World Health Organization will determine when enough countries have tamped down their COVID-19 cases sufficiently - or at least, hospitalizations and deaths - to declare the pandemic officially over. Exactly what that threshold will be isn´t clear.

But even when that happens, some parts of the world still will struggle - especially low-income countries that lack enough vaccines or treatments - while others more easily transition to what scientists call an 'endemic' state.

They´re fuzzy distinctions, said infectious disease expert Stephen Kissler of the Harvard T.H. Chan School of Public Health. He defines the endemic period as reaching 'some sort of acceptable steady state' to deal with COVID-19.

The omicron crisis shows we´re not there yet but 'I do think we will reach a point where SARS-CoV-2 is endemic much like flu is endemic,' he said.

For comparison, COVID-19 has killed more than 800,000 Americans in two years while flu typically kills between 12,000 and 52,000 a year.

Exactly how much continuing COVID-19 illness and death the world will put up with is largely a social question, not a scientific one.

'We´re not going to get to a point where it´s 2019 again,' said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security. 'We´ve got to get people to think about risk tolerance.'

Dr. Anthony Fauci, the top U.S. infectious disease expert, is looking ahead to controlling the virus in a way 'that does not disrupt society, that does not disrupt the economy.'

In his interview with PIX 11 on Monday, Fauci said that if people comply with the CDC recommendations and get a booster shot 'we will get through this quicker.'

Another Covid variant has been found in France, according to scientists.

The mutant strain has 46 mutations that are thought to make it both more vaccine-resistant and infectious than the original virus.

Some 12 cases have been spotted so far near Marseille, with the first linked to travel to the African country Cameroon.

But there is little sign that it is outcompeting the dominant Omicron variant, which now makes up more than 60 per cent of cases in France.

The strain was discovered by academics based at the IHU Mediterranee Infection on December 10, but has not spread rapidly since.

It is yet to be spotted in other countries or labelled a variant under investigation by the World Health Organization.

Professor Philippe Colson, who heads up the unit that discovered the strain, said: 'We indeed have several cases of this new variant in the Marseille geographical area.'We named it "variant IHU". Two new genomes have just been submitted.'

The variant has been dubbed B.1.640.2 and its discovery was announced in a paper posted on medRxiv. This has not been published in an academic journal.

Scientists say the lineage is genetically different to B.1.640, which is thought to have emerged in the Democratic Republic of Congo in September.

Tests show the strain carries the E484K mutation that is thought to make it more resistant to vaccines.

It also has the N501Y mutation — first seen on the Alpha variant — that experts believe can make it more transmissible.

It is a distant relative of Omicron, which scientists say likely evolved from an older virus.

Omicron — or B.1.1.529 — carries around 50 mutations and appears to be better at infecting people who already have a level of immunity. But a growing body of research proves it is also much less likely to trigger severe disease.




Monday, January 03, 2022

UK: My model has got it right on the Covid pandemic; and it tells me we don't need a new lockdown

By Philip Thomas, a Visiting Academic Professor at the University of Bristol

That alarm bells are ringing loudly in response to the rapid spread of the Omicron variant is no secret in Whitehall.

Civil servants are reportedly drawing up urgent plans for further restrictions and yesterday's emergency Cabinet meeting was perhaps a sign of things to come.

So far, ministers are resisting further Covid curbs, though Boris Johnson made clear that a clampdown was being held in 'reserve'.

Throughout the pandemic, ministers have frequently insisted that they 'follow the science' in their decision-making.

And a key ingredient of the mounting pressure for action being demanded in some quarters can be found in the guidance produced by the members of the consistently doom-laden Scientific Advisory Group for Emergencies (Sage), whose oft-criticised modelling has been central in the development of official policy over the past two years.


Their latest document is typically grim, with its claim that there could be 6,000 deaths a day in a new Covid wave, more than three times higher than the peak daily toll last January (when we didn't have mass vaccination) and equating to 180,000 deaths a month, more than we've seen the entire pandemic.

Despite these arguably hysterical numbers leading bulletins, Sage does concede that this represents their 'worst-case scenario' if the Government sticks to Plan B and imposes no further measures.

Yet even with that caveat, we should all be deeply concerned about Sage's modelling.

Doubts about the reliability of Sage's figures are hardly new, but scepticism will have only been increased following the remarkable Twitter exchange between Fraser Nelson, the editor of the Spectator magazine, and Professor Graham Medley, chair of Sage's modelling committee, over the weekend.

Puzzled by the gap between the reassuring reports from South Africa and Sage's dark forebodings, Nelson asked Medley how the group's conclusion was reached.

If, as the South Africans think, Omicron is mild and there is no need for lockdown, why didn't Sage include this scenario 'given that this is a very plausible option that changes outlook massively', asked Nelson. Simple enough.

But then came Medley's telling reply: 'Decision-makers are generally only interested in situations where decisions have to be made.'

Does Sage exclusively model bad outcomes that require further restrictions and omit more welcome outcomes for which no action would be required, even if such scenarios are just as likely to occur, Nelson wondered?

Then came the hammer blow: 'We generally model what we are asked to model,' Medley replied.

It was an extraordinary exchange and hardly how most people expect scientific advice to be provided.

In reaching its decisions, surely the Government needs to know the likelihood of all scenarios rather than just an outline of the worst possible cases?

Those who advocate a return to lockdown to halt the transmissibility of Omicron, for instance, ignore the wider impact of such a drastic measure on the economy, the backlog of other NHS treatments, mental health, domestic abuse and education.

The latest Government figures, published this month, show Britain's GDP is still 0.8 per cent lower than it was before the pandemic.

Without a strong economic rebound, it's probable that more people will be killed by the financial consequences of lockdown restrictions than ever died with Covid.

Even the more limited restrictions of Plan B are having a devastating effect on the hospitality trade, the travel industry and the entertainment sector.

Once again there is a clamour for the Chancellor Rishi Sunak to produce a rescue package out of thin air to tide businesses over this fraught winter, even though he has already spent more than £400 billion of taxpayers' money on support programmes, with debts that will saddle future generations to the tune of £2.2 trillion.

We have, of course, known about Omicron for less than a month and it would certainly be foolish to be too dismissive of its potential impact.

But nevertheless, a counter-weight must be offered against Sage's gloom. I can do that through the mathematical model I developed at Bristol University (the Predictor Corrector Covid Filter, or PCCF) which has proved a highly accurate forecaster of the progress of the pandemic.

Early in the new year, active Omicron infections may reach two and a half million, which added to the slowly declining Delta infections will generate a combined total peak of 3.5 million cases.

But while that number sounds huge, it does not necessarily spell the disaster that Sage has outlined.


I predict that Omicron's rise will be very fast — as seen already in London — but that will equate to a decline at almost the same speed, so that active infections are likely to be below where we are now in a month's time, and set to fade away as we move into spring.

That outlook is backed up by evidence from South Africa, who are a month ahead of us, where the National Institute of Communicable Diseases estimates that the fatality ratio (the percentage of those infected dying) is less than half the level it was for the Delta wave last winter, and more than four times lower for the particularly vulnerable 70 to 79-year-olds.

The relative mildness of the new strain is confirmed not only by the fact that hospital stays are much shorter for Omicron patients — around three days as opposed to 11 for Delta patients — but also that fewer such patients need oxygen or intensive care when in hospital.

That does not mean we will have it easy. The PCCF model indicates that deaths will certainly rise above the current level of 100 per day.

But even so, they are unlikely to go beyond 500 a day in England. This total, of course, represents a very significant number of individual tragedies, but is far below the daily peak of over 1,800 UK-wide deaths last January.


In the same vein, according to the PCCF, hospitalisations may reach around 3,000 per day, higher than the current rate of 800 but still below January's peak of 4,100 — a number that was achieved during a full national lockdown, and which was considered not to have overwhelmed the NHS.

Indeed, my modelling predicts numbers will remain manageable without the introduction of any further Covid curbs.

As I say, we cannot be complacent, but nor should we fall into despair or panic. I see no justification for further restrictions, let alone another lockdown, whatever Sage propounds.

The Government is right to see the booster programme as our main defence, just as we should also put our trust in the good sense and self-restraint of the British people.

Those who are vulnerable or risk-averse are already adjusting their behaviour without the need for more bureaucratic edicts. We all want to have a good Christmas, after all.

We must remember, too, that an uptick in respiratory deaths and hospitalisations is normal for winter.

Give in to the doom-mongers yet again, and we risk being trapped in a relentless cycle of authoritarian controls.

Normality beckons if the Government continues to hold its nerve, keep to the pragmatic path and refuse to be bullied into fearful measures by modelling that is predicated on exaggerated fears.


Compilation of nurse whistleblowers

The world has been embroiled in the most devastating public health crisis in more than a century. COVID-19 has disrupted the entire world.

It has been a catastrophe. However, the deadliness of COVID-19 has been made exponentially worse by terrible policies. Medical bureaucrats have lied and misled so often, they’ve lost the trust of the people they were entrusted to protect. These policies are even killing people.

Lockdowns have created a global catastrophe aside from what the virus caused. An entire generation of children has been harmed by unnecessary school closures. Even a vaccine critical to saving the lives of the elderly and immune compromised has been abused.

Nurses have been on the COVID frontline since day one. They have seen it all firsthand. These dedicated healthcare professionals have been heroes. However, they have consistently reported some harsh realities that mainstream media ignore.

A recent video compilation from nurses worldwide sheds a disturbing light on the potential adverse side effects caused by the COVID vaccine. Like anything which goes contrary to the bureaucratic narrative, these concerns are being buried.

However, Gateway Pundit compiled a series of video interviews with nurses from around the world. Every one of these healthcare professionals spoke candidly. Many have either quit or gotten fired. What they openly share is shocking.

One former nurse from Canada reported watching elderly patients being held down against their will and vaccinated. She witnessed full-term miscarriages within days of getting a COVID shot. Nurses reported elderly patients showing up sick with COVID days after getting vaccinated.

Other nurses shared about how people were never tested for COVID, despite showing profound symptoms, until after they died. Many nurses nearly came to tears during their testimony. In addition, some bemoaned how hospital administrators harassed them over vaccine mandates.

Paramedics and other healthcare workers also shared alarming concerns towards vaccine mandates and the safeness of the COVID vaccine itself. RN Collette Martin answered questions from Louisiana State Representative - Health and Welfare Committee chair Larry Bagley.

The 17-year veteran RN strongly cautioned against the COVID vaccine for children. She also stressed that adult reactions to COVID vaccine side effects are being ignored. However, she admonished medical professionals for ignoring these dangers arising in vaccinated children.

These dangers far outweigh any advantages. Children are now more prone to dying from vaccine complications than they are from COVID. Martin continued to express her concern about what is an obvious cover-up of vaccine related dangers.

She insisted that thousands of patient deaths are a direct result of the COVID vaccine, not the virus. Martin insisted that an alarming percentage of these deaths are not being reported to the Vaccine Adverse Effects Reporting System (VAERS).

She indicated that many of her fellow nurses do not even know what VAERS is. Medical bureaucrats informed her that the VAERS database is a poor determiner of vaccine side effects. Like many in her field, Martin wanted to know why.

These complicit medical bureaucrats had no viable answer. Another healthcare worker from a U.S. hospital stressed that the numbers of COVID vaccine-related deaths on VAERS has doubled within the last nine months. These are the ones being reported.

This shocking revelation is even more disturbing when we consider reports that a huge bulk of vaccine-related deaths is not being reported. The more we hear from these brave healthcare professionals, the more frightening are the conclusions.

A virus leaked out of a virology lab in Wuhan, China. This lab received funding, deviously funneled through U.S. channels, using taxpayer money. The lab was practicing dangerous gain-of-function research on deadly coronaviruses. Safety protocols at the lab were horrific.

It is a scam. It is criminal. We’re barely one year from the official release of the COVID vaccines. Thousands have died from the shot already. As years pass, how many more health crises will be experienced




Sunday, January 02, 2022

Crooked statistics about vaccination status

False statistics and misinformation are being used to push the baseless narrative that most COVID-19 hospital patients are unvaccinated.

On Friday, September 17, the CDC published a study that refutes the common claim that Covid-19 is a “pandemic of the unvaccinated.” Coauthored by more than 50 MD’s and Ph.D.’s, the study contains data on the vaccine status of adults hospitalized with Covid-19 at 21 U.S. hospitals across 18 states during March to August of 2021.

Contrary to assertions from the Associated Press and Anthony Fauci that fully vaccinated people comprise only 1% of those being hospitalized or killed by C-19, the study found that 13% of patients hospitalized with C-19 had been fully vaccinated. Moreover, that 13% figure is just the tip of iceberg because the authors excluded from their study a large group of hospitalized C-19 patients, the bulk of whom were likely vaccinated.

About half of the omitted group and 27% of the C-19 patients in these hospitals were people with “immunocompromising conditions,” such as cancer, HIV, rheumatoid arthritis, psoriasis, scleroderma, and Crohn’s disease. In the words of an FDA official and 18 other coauthors published in a medical journal, “immunocompromised individuals” were “prioritized for early immunization” and are “plausibly more likely to be offered and seek vaccination” because they are highly vulnerable to C-19.

On September 21, Just Facts asked Dr. Wesley Self, the lead author of the study, to release the data on the vaccination status of the C-19 patients with immunocompromising conditions. He has not replied.

The authors of the CDC study also excluded another 25% of all people hospitalized with C-19 because they were partially vaccinated, “received a Covid-19 vaccine other than Moderna, Pfizer-BioNTech, or Janssen [J&J],” or “received doses of two different Covid-19 vaccine products.”

Accounting for all of the C-19 patients in these hospitals, including those the authors excluded, a majority may have been fully or partially vaccinated against Covid:

Filling the gap left by vagueness of the CDC’s study, a precise measure of the vaccine status of people who died from the Covid-19 Delta variant is available from the United Kingdom, where the government keeps detailed healthcare records on nearly all citizens. Relevantly, the U.S. and UK have very similar C-19 death rates and had roughly equivalent vaccination rates over the period of the CDC study.

In the UK from February through August 2021, 62% of all Covid-19 Delta variant deaths were among the fully vaccinated. This amounts to a conclusive majority in a dataset with virtually every death included.

Seeing Through False Statistics

The story behind the talking point that Covid-19 is “a pandemic of the unvaccinated” is a textbook case of how false statistics are born and proliferate. Hence, it provides valuable insights about the dangers of blind trust and how to recognize deceitful rhetoric.

Late in June 2021, the Associated Press published an article titled, “Nearly All COVID Deaths in US Are Now Among Unvaccinated.” Written by Carla K. Johnson and Mike Stobbe, it was republished or cited by more than 100 media outlets and so-called fact checkers like PBS, Snopes, Bloomberg, the Boston Globe, the Los Angeles Times,, Yahoo News, and WebMD.

The article claims the AP conducted an “analysis” that found only 1.1% of all C-19 hospitalizations and 0.8% of C-19 deaths in May were due to “breakthrough infections in fully vaccinated people.” While using those decimal points that convey a false sense of precision, the authors slipped in this craftily worded admission: the AP calculated these rates based on “figures provided by the Centers for Disease Control and Prevention,” but the CDC has not published such rates due to “limitations in the data.”

Those limitations, in the words of the AP, include the reality that “some” states are “more aggressive than others in looking for such cases.” The word “looking” is a coy way of saying that the states don’t have a comprehensive system to count these deaths, a fact that throws the entire analysis into doubt.

With a subtle nod to that reality, the AP confesses that the “data probably understates” the number of vaccinated people who died from Covid-19. Compare that softly worded disclosure to the CDC’s explicit warning that its data on breakthrough infections “relies on passive and voluntary reporting, and data might not be complete or representative.” On August 25, the CDC strengthened that language to make clear that the “data are not complete or representative.”

Put simply, the AP’s statistics are meaningless because they are based on materially incomplete data. That was evident from the outset from a close look at the AP’s methodology, and it is now undeniable given the CDC study and UK data detailed above. Again, these indicate that fully vaccinated people comprise about 50% of all Covid-19 hospitalizations and deaths, not 1% as reported by the AP.

Nevertheless, Fauci appeared on the July 4th edition of NBC’s Meet the Press with Chuck Todd and parroted the AP’s bogus stat without mentioning any of its caveats. “If you look at the number of deaths,” declared Fauci, “about 99.2% of them are unvaccinated. About 0.8% are vaccinated. No vaccine is perfect. But when you talk about the avoidability of hospitalization and death, Chuck, it’s really sad and tragic that most all of these are avoidable and preventable.”

As Fauci uttered this misinformation, Todd, the political director of NBC News, never expressed a hint of skepticism. Acting like a mouthpiece instead of a journalist, Todd ended the segment by praising Fauci for “focusing” on his job and this “massive success story when it comes to vaccines and what this government-led effort did.”

Instead of correcting the AP and Fauci for misrepresenting CDC data, the director of the CDC, Dr. Rochelle Walensky, amplified it. During a July 16th White House press conference with Fauci by her side, Walensky stated that “over 97 percent of people who are entering the hospital right now are unvaccinated” and that Covid-19 “is becoming a pandemic of the unvaccinated.”

In turn, media outlets acted as megaphones for Fauci and Walensky without a word of critical analysis. This involved reports from the likes of ABC News, NPR, The Hill, CNN, Politico, Rolling Stone, USA Today, The Guardian, and the Washington Post, as well as three separate articles from the New York Times.

The Times later conducted its own analysis using the same ruse as the AP, reporting that fully vaccinated people were only 0.1% to 5% of Covid-19 hospitalizations across 40 states since vaccinations began. Buried near the end of the story, the Times revealed that it calculated these rates by lumping C-19 patients “with unknown vaccination status” into the “data for individuals who were not fully vaccinated.”

One week later, the Times began walking back those claims. On August 17, it alleged that reports from seven states with “the most detailed data” indicate that “breakthrough infections accounted for 12 percent to 24 percent of Covid-related hospitalizations.”

Despite those larger figures—which are still far removed from reality—the Times did not correct any of its earlier articles touting figures of 1% to 3% accompanied by quotes like this:

“The takeaway message remains, if you’re vaccinated, you are protected,” said Dr. Celine Gounder, an infectious disease specialist at Bellevue Hospital Center in New York. “You are not going to end up with severe disease, hospitalization or death.”


The most glaring lesson from this affair is that people entrusted to protect and inform the public are untrustworthy. Government officials with prestigious credentials and prominent media outlets repeatedly misreported the facts of this simple matter with life-or-death consequences. Thus, it is crucial to learn and apply proven methods to sort out the claims that surround important issues.

Secondly, Covid-19 still poses a considerable risk to some fully vaccinated people because a vaccine is only as good as each person’s immune system. Vaccines don’t directly attack virulent microbes in the same manner as antibiotics or anti-viral medicines. Instead, vaccines trigger people’s immune systems to react more quickly than usual and kill pathogens before they can do harm. If a person’s immune system is compromised by factors like poor general health, old age, obesity, immunosuppressing drugs, or lack of sleep, a vaccine will be less effective or ineffective.

Also, the currently available C-19 vaccines create an immune response to only one part of the SARS-CoV-2 virus (the “Spike” protein). This produces narrower immunity than exposure to the actual virus. In accord with this fact, a study in Israel that has not yet undergone peer review has found that the Pfizer vaccine is much less effective in protecting against the Delta variant than naturally acquired immunity.

Third, none of the above means that C-19 vaccines are ineffective. Randomized controlled trials, which are the gold standard for determining clinical efficacy, have found that the C-19 vaccines significantly reduce the odds of having a bout of severe Covid-19. The Pfizer vaccine, for example, reduced the odds of severe C-19 by 71% to 100% for people who were not immunocompromised over a period of six months. Whether or not this protection lasts and if the benefits exceed the harms will be the subjects of upcoming article


Doctors with covid-19 put early at-home treatment to the test

Two physicians who are leading the charge on early at-home COVID-19 treatment to reduce hospitalization and death, have themselves become infected with the virus and following the regimen they, themselves preach

Two physicians who are leading the charge on early at-home COVID-19 treatment to reduce hospitalization and death, have themselves become infected with the virus and following the regimen they, themselves preach.

The surprise announcement of their illnesses came during an October 27 webcast by Peter McCullough, M.D., a public health expert, researcher and cardiologist at the Baylor Heart and Vascular Institute in Dallas, Texas, was scheduled to discuss the COVID treatment algorithm he helped design and was published August 7 in the American Journal of Medicine. During the presentation, McCullough revealed he was currently sick with the virus and is following his own protocol.

“I fully expect to have a prompt recovery, to return to work and avoid the risk of hospitalization and death,” said McCullough.

Moderator Jean-Pierre Kiekens then brought in another champion of early at-home treatment to the discussion, Brian Tyson, M.D., a family physician in California. Tyson said, he too, tested positive with the virus, and felt remarkably better after two days of the at-home regimen.

Physicians Avoiding the Hospital

McCullough said he tested positive the day before his presentation but showed symptoms several days earlier. The day before his test result came back, McCullough said he began treatment for his particular cohort in the algorithm, a patient over age 50 and with two or more pre-existing conditions (asthma, heart disease).

McCullough’s home regimen consists of the anti-viral drug, Ivermectin (IVM), the antibiotic, Azithromycin, zinc, vitamin D, an increase in his daily dose of aspirin for mild heart disease, and plenty of fresh air to avoid re-inoculation. If his symptoms don’t improve in 5 days, McCullough says he will start taking prednisone.

Tyson said he also used IVM in his treatment and noticed a huge improvement in symptoms on day two. “It is still lingering a little, bit. It’s more like a head cold, but the IVM seemed to really knock it out,” said Tyson.

The IVM and the antibiotic are “off label” use, meaning, they have been approved for other illnesses, not for COVID-19. Both physicians looked well, but tired, and McCullough sneezed a few times and sounded congested. McCullough said he ran six miles, four days earlier.

The Case for Early Treatment

There are four pillars to controlling a pandemic, stated McCullough, but the media and public health authorities focus on only three of them, with Dr. Anthony Fauci’s presentation on the Yale Global Health Network October 26, being a case in point. “The entire message was contagion control, shelter in place, and wait for a vaccine. There was no mention of early home treatment.” Incidentally, Fauci’s presentation on Zoom was standing room only, McCullough’s presentation had 57 participants.

People are going to get sick with COVID-19 if they haven’t already, said McCullough. “Early home treatment can be the only method for reducing hospitalizations and death once an individual gets sick. The hospital should only be a safety net for survival. It should not be the first place of treatment” said McCullough. McCullough says the U.S. should follow what India and Brazil have done and make available at-home COVID-19 treatment kits.